Sean Patrick Lawler, Chief Accounting Officer of CalciMedica, Inc. (NASDAQ:CALC), filed an initial statement of beneficial ownership on November 19, 2026, with a triggering event date of November 10, 2026.
Key Highlights
- Reporting person: Sean Patrick Lawler, identified as Chief Accounting Officer of CalciMedica, Inc.
- Triggering event date: November 10, 2026, as stated in the filing.
- Derivative securities: Twelve Employee Stock Options (Right to Buy) covering Common Stock are listed in Table II, all held directly.
- Largest single option grant: 50,000 shares of Common Stock at an exercise price of $1.74, with vesting beginning September 24, 2026.
- No non-derivative securities: Table I, covering directly or indirectly held common shares, contains no entries.
- Exercise prices range: From $1.74 to $86.70 per share across the listed options.
Lawler's Initial Ownership Disclosure at CalciMedica
According to the filing, Sean Patrick Lawler submitted this Form 3 as an initial statement of beneficial ownership upon becoming subject to Section 16(a) reporting obligations at CalciMedica, Inc. CalciMedica is a clinical-stage biopharmaceutical company listed on NASDAQ under the symbol CALC. Lawler is identified in the filing solely as Chief Accounting Officer, with no directorship or 10% ownership designation checked.
The filing reports no non-derivative securities in Table I, meaning no direct or indirect holdings of Common Stock shares are listed. All beneficial ownership disclosed consists of derivative securities in the form of Employee Stock Options (Right to Buy), each held directly. The options cover varying share amounts and carry exercise prices ranging from $1.74 to $86.70 per share, as stated in Table II of the filing.
The filing's explanation of responses details the vesting schedules for the options. Several are described as immediately exercisable as of the filing date. Others vest in equal monthly installments of 1/48th of the total shares subject to each option, over a four-year period following specified commencement dates. The most recently granted option, covering 50,000 shares at $1.74 per share, began vesting on September 24, 2026, according to the filing.
What Was Disclosed
CalciMedica's Chief Accounting Officer, Sean Patrick Lawler, filed an initial beneficial ownership statement disclosing twelve Employee Stock Options covering Common Stock, all held directly, with no common shares reported in Table I. The filing was signed and submitted on November 19, 2026.


Please wait processing your request...